May 10 |
Iovance Q1 Earnings Review: Not Enough Data To Draw Conclusions On Amtagvi
|
May 10 |
Why Iovance Stock Is Down 18% Today
|
May 10 |
Iovance Biotherapeutics' Patient Selection for Amtagvi Launch Minimizing Attrition, Truist Securities Says
|
May 10 |
Iovance Biotherapeutics Inc (IOVA) Q1 2024 Earnings: Aligns with EPS Projections Amidst Strong ...
|
May 10 |
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Earnings Call Transcript
|
May 10 |
Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
|
May 10 |
Iovance Biotherapeutics, Inc. (IOVA) Q1 2024 Earnings Call Transcript
|
May 9 |
Iovance Biotherapeutics reports Q1 results
|
May 9 |
Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates
|
May 9 |
How Is The Market Feeling About Iovance Biotherapeutics?
|